These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29663358)

  • 1. A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda.
    Mpunga T; Znaor A; Uwizeye FR; Uwase A; Munyanshongore C; Franceschi S; Clifford GM
    Int J Cancer; 2018 Sep; 143(6):1348-1355. PubMed ID: 29663358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
    Mukhtar F; Ilozumba M; Utuama O; Cimenler O
    JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.
    Montoto S; Shaw K; Okosun J; Gandhi S; Fields P; Wilson A; Shanyinde M; Cwynarski K; Marcus R; de Vos J; Young AM; Tenant-Flowers M; Orkin C; Johnson M; Chilton D; Gribben JG; Bower M
    J Clin Oncol; 2012 Nov; 30(33):4111-6. PubMed ID: 23045581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
    Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
    Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.
    ; Bohlius J; Schmidlin K; Costagliola D; Fätkenheuer G; May M; Caro-Murillo AM; Mocroft A; Bonnet F; Clifford G; Karafoulidou A; Miro JM; Lundgren J; Chene G; Egger M
    Antivir Ther; 2009; 14(8):1065-74. PubMed ID: 20032536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing Patterns of Lymphoma in the Antiretroviral Therapy Era in Johannesburg, South Africa.
    Wiggill T; Mayne E; Perner Y; Vaughan J
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):252-260. PubMed ID: 34354010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-Related Lymphoproliferative Diseases in the Era of Combination Antiretroviral Therapy.
    Castelli R; Schiavon R; Preti C; Ferraris L
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(3):175-180. PubMed ID: 32294049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
    Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR;
    AIDS; 2011 Jul; 25(11):1395-403. PubMed ID: 21572307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.
    van Leeuwen MT; Vajdic CM; Middleton MG; McDonald AM; Law M; Kaldor JM; Grulich AE
    AIDS; 2009 Oct; 23(16):2183-90. PubMed ID: 19734774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing HIV and Hodgkin lymphoma in the twenty-first century.
    Aries J; Montoto S
    Curr Hematol Malig Rep; 2014 Sep; 9(3):227-32. PubMed ID: 24906351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
    International Collaboration on HIV and Cancer
    J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
    Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
    J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer in HIV-infected persons from the Caribbean, Central and South America.
    Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
    Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
    AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic trends in HIV-associated lymphomas.
    Clarke CA; Glaser SL
    Curr Opin Oncol; 2001 Sep; 13(5):354-9. PubMed ID: 11555712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.